Valuation: Qiagen N.V.

Capitalization 972.32Cr 835.51Cr 779.14Cr 723.99Cr 1.35TCr 88TCr 1.46TCr 8.96TCr 3.52TCr 42TCr 3.65TCr 3.57TCr 1,54800Cr P/E ratio 2025 *
23.7x
P/E ratio 2026 * 21x
Enterprise value 1TCr 859.36Cr 801.37Cr 744.65Cr 1.39TCr 90TCr 1.5TCr 9.21TCr 3.62TCr 43TCr 3.75TCr 3.67TCr 1,59200Cr EV / Sales 2025 *
4.81x
EV / Sales 2026 * 4.51x
Free-Float
94.35%
Yield 2025 *
0.28%
Yield 2026 * 0.32%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.11%
1 week-4.62%
Current month-0.29%
1 month-0.84%
3 months-5.04%
6 months-6.84%
Current year-0.29%
More quotes
1 week 46.41
Extreme 46.41
49.01
1 month 46.41
Extreme 46.41
50.07
Current year 46.41
Extreme 46.41
50.07
1 year 39.61
Extreme 39.6105
54.61
3 years 38.78
Extreme 38.7765
56.76
5 years 38.78
Extreme 38.7765
65.86
10 years 23.11
Extreme 23.113
65.86
More quotes
Manager TitleAgeSince
Chief Executive Officer 61 07/10/2019
Director of Finance/CFO 58 01/01/2004
Chief Operating Officer - 01/04/2022
Director TitleAgeSince
Director/Board Member 71 01/01/2004
Director/Board Member 77 01/06/2011
Director/Board Member 54 01/01/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.11%-4.62%-5.23%-16.36% 972.32Cr
+0.55%+2.22%+4.54%+11.87% 4.91TCr
+0.29%+0.43%+18.05%+8.75% 4.11TCr
+5.11%+9.59%+90.16%+29.71% 3.88TCr
+3.27%+3.76%+25.05%+42.80% 3.27TCr
+2.37%+50.22%+181.77%+298.64% 2.32TCr
-26.23%-1.48%+24,147.39%+4,036.79% 1.61TCr
+1.54%-0.08%+72.84%+166.20% 1.71TCr
-1.07%+4.84%+56.99%+11.46% 1.5TCr
+1.74%-9.03%-15.92%-18.35% 1.4TCr
Average -1.57%+6.53%+2,457.56%+457.15% 2.57TCr
Weighted average by Cap. -0.24%+7.26%+1,555.77%+303.40%
See all sector performances

Financials

2025 *2026 *
Net sales 207.7Cr 178.48Cr 166.44Cr 154.66Cr 288.57Cr 19TCr 311.16Cr 1.91TCr 751.83Cr 8.96TCr 778.93Cr 762.96Cr 33TCr 220.23Cr 189.25Cr 176.48Cr 163.99Cr 305.97Cr 20TCr 329.93Cr 2.03TCr 797.18Cr 9.5TCr 825.92Cr 808.98Cr 35TCr
Net income 42Cr 36Cr 34Cr 31Cr 58Cr 3.8TCr 63Cr 387.38Cr 152.21Cr 1.81TCr 157.7Cr 154.46Cr 6.69TCr 46Cr 39Cr 37Cr 34Cr 64Cr 4.15TCr 69Cr 423.16Cr 166.27Cr 1.98TCr 172.26Cr 168.73Cr 7.31TCr
Net Debt 28Cr 24Cr 22Cr 21Cr 39Cr 2.51TCr 42Cr 255.64Cr 100.44Cr 1.2TCr 104.07Cr 101.93Cr 4.42TCr 22Cr 19Cr 17Cr 16Cr 30Cr 1.96TCr 32Cr 199.42Cr 78Cr 934.28Cr 81Cr 80Cr 3.45TCr
More financial data * Estimated data
Logo Qiagen N.V.
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Employees
5,700
More about the company
Date Price Change Volume
13/26/13 47.20 $ -0.11% 11,78,569
12/26/12 47.25 $ -2.15% 14,32,772
09/26/09 48.29 $ -0.33% 12,76,855
08/26/08 48.45 $ -2.71% 11,84,645
07/26/07 49.80 $ +0.64% 16,47,084

Delayed Quote Nyse, January 14, 2026 at 02:30 am IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
47.20USD
Average target price
52.82USD
Spread / Average Target
+11.91%
Consensus

Quarterly revenue - Rate of surprise